Patients might be able to avoid or better manage surprise ambulance bills; Brexit causes providers to leave London and prevents others from entering Britain at all; new research provides insight on antibiotic resistance.
An ambulance trip can stick patients with surprising and expensive bills, such as more than $8000 for a ride from one hospital to another or $3600 for a 4-mile ride. The Washington Post recently reported that at least one-fourth of surprising medical bills were related to ambulance concerns. The paper is also providing a guide for how to handle a surprise ambulance bill, such as asking your insurer to cover more of the cost or getting a discount on a payment plan through the ambulance service’s billing department.
Britain’s National Health Service (NHS) had suffered from staffing shortages for years, but Brexit will make the situation more difficult. According to The New York Times, it will now be more difficult to recruit nurses from the continent, and those European Union (EU) citizens already living in Britain are uncertain about their future legal status. As a result, almost 10,000 European healthcare professionals quit the NHS in the year after Brexit, and the number of nurses from the EU registering to work in Britain is down almost 90%.
Bacteria can gain antibiotic resistance genes even when there is no antibiotic present. New research has found that when 2 cells knock into one another they can transfer DNA, which helps to transfer the resistance to new cells, reported STAT. However, the researchers were able to reverse resistance for some of the plasmids studied. The spread of resistance was prevented in the remaining plasmids, providing a new hope for combatting the growing threat of antibiotic resistance.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More